Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
89.23 CHF | +0.41% | +0.34% | +5.15% |
05:01pm | FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications | MT |
01:00pm | Peptidream Announces Expansion of Peptide Discovery Collaboration with Novartis | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.15% | 199B | |
+32.49% | 664B | |
+29.29% | 567B | |
-7.10% | 354B | |
+19.17% | 330B | |
+4.46% | 286B | |
+13.32% | 234B | |
-9.78% | 196B | |
-5.06% | 148B | |
-10.75% | 145B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- NOVARTIS AG : Receives a Sell rating from JP Morgan